Iovance Biotherapeutics, Inc. vs SillaJen

Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc.

Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated

925 employees · est. 2007 · San Carlos, United States

VS
SillaJen logo

SillaJen

28 employees · est. 2003 · San Francisco, United States

SillaJen is the older company (2007 vs 2003); Iovance Biotherapeutics, Inc. is the larger of the two.

Side-by-Side Comparison

Iovance Biotherapeutics, Inc. SillaJen
Founded
2007 2003 older
Headquarters
San Carlos, United States San Francisco, United States
Employees
925 larger 28
Industry
Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
IPO Venture round
Total Funding
$1.78B $12.00M
Funding Rounds
10 1
Services
TIL Therapy Development, Clinical Research, Manufacturing at Cell Therapy Center, Scientific Publications & Presentations, Pipeline Development for Advanced Solid Tumor Cancers Not tracked yet
Target Customers
Patients with Advanced Solid Tumor Cancers, Healthcare Providers, Clinical Researchers, Pharmaceutical Investors Not tracked yet
Taxonomy
Patient-Centric OrganizationCancer Treatment InnovationTumor Infiltrating Lymphocytes (TIL) TherapyAutologous T-Cell TreatmentImmunotherapy DevelopmentSolid Tumor Focus +9 Not tracked yet
Website
iovance.com sillajen.com
Iovance Biotherapeutics, Inc. logo

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. is a biotechnology company founded in 2007 with a mission to revolutionize cancer treatment through its innovative tumor infiltrating lymphocyte (TIL) therapies. As a patient-centric organization, Iovance harnesses the human immune system's potential to target and elimi...

SillaJen logo

About SillaJen

SillaJen Biotherapeutics, Inc. is a biotechnology company headquartered in San Francisco, founded in 2003. The company focuses on the research, development, and manufacturing of oncolytic viruses to treat cancer. It operates in one of the largest biotech clusters in the world and handles Clinical Op...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Iovance Biotherapeutics, Inc. and SillaJen for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Iovance Biotherapeutics, Inc. or SillaJen moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Iovance Biotherapeutics, Inc. was founded in 2007, based in San Carlos, United States, with 925 employees. Iovance Biotherapeutics, Inc. is a biotechnology company founded in 2007 with a mission to revolutionize cancer treatment through its innovative tumor infiltrating lymphocyte (TIL) therapies. As a pat. SillaJen was founded in 2003, based in San Francisco, United States, with 28 employees. SillaJen Biotherapeutics, Inc. is a biotechnology company headquartered in San Francisco, founded in 2003. The company focuses on the research, development, and manufacturing of oncolytic viruses to t.
Iovance Biotherapeutics, Inc. has raised $1.78B and SillaJen $12.00M. Latest stage: Iovance Biotherapeutics, Inc. IPO, SillaJen Venture round.
Both work in Biotechnology and Health Care.

Compare Iovance Biotherapeutics, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Iovance Biotherapeutics, Inc. on 9 Jun 2026, and SillaJen on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes